Similar articles

• The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate).

  Nwokolo CU, Mistry P, Pounder RE. Nwokolo CU, et al. Aliment Pharmacol Ther. 1990 Apr;4(2):163-9. doi: 10.1111/j.1365-2036.1990.tb00461.x. Aliment Pharmacol Ther. 1990. PMID: 2104082
• Absorption of salicylate and bismuth from a bismuth subsalicylate--containing compound (Pepto-Bismol).

  Pickering LK, Feldman S, Ericsson CD, Cleary TG. Pickering LK, et al. J Pediatr. 1981 Oct;99(4):654-6. doi: 10.1016/s0022-3476(81)80285-5. J Pediatr. 1981. PMID: 7277115 No abstract available.
• Pepto-Bismol mimicking pancreatic calcification.

  Bernstein D, Barkin JS. Bernstein D, et al. Am J Gastroenterol. 1992 Nov;87(11):1677-9. Am J Gastroenterol. 1992. PMID: 1442703 No abstract available.
• Bismuth subsalicylate: history, chemistry, and safety.

  Bierer DW. Bierer DW. Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S3-8. doi: 10.1093/clinids/12.supplement_1.s3. Rev Infect Dis. 1990. PMID: 2406853 Review.
• [Classic triple therapy for Helicobacter pylori infection].

  Takahashi S, Tanaka A. Takahashi S, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:420-2. Nihon Rinsho. 2002. PMID: 11979818 Review. Japanese. No abstract available.